Evofem Biosciences Inc (OTCQB:EVFM)
| 0.0365 Delayed Data As of Mar 22 |  +0.009 / +32.73%Today’s Change | 0.01 Today|||52-Week Range 6.19 | -42.97% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Assets | Cash | 12.1M | 1.3M | 600.0K | 51.1M | |
| Short Term Investment Cash | -10.8M | -10.8M | -1.2M | 50.5M | ||
| Cash & Short Term Investments | 12.5M | 1.8M | 600.0K | 51.1M | ||
| Receivables | Receivables | 302.0K | 316.0K | 253.0K | 250.0K | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 417.0K | -- | 362.0K | 1.2M | |
| Other Current Assets | 183.0K | 401.0K | 130.0K | 357.0K | ||
| Current Assets | 13.4M | 2.5M | 1.3M | 52.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 1.2M | 1.2M | 1.8M | 1.7M | |
| Depreciation | -538.0K | -604.0K | -670.0K | -736.0K | ||
| Other Assets | 450.0K | 439.0K | 467.0K | 372.0K | ||
| Total Assets | 15.0M | 4.0M | 3.2M | 54.4M | ||
| Liabilities | Accounts Payable | 8.0M | 8.9M | 11.9M | 8.6M | |
| Short Term Debt | 0.00 | 4.0M | 4.8M | 580.0K | ||
| Accrued Expenses | 14.3M | 11.2M | 11.3M | 7.0M | ||
| Other Current Liabilities | 14.4M | 11.5M | 11.5M | 7.2M | ||
| Other Liabilities | 25.0M | 27.3M | 32.1M | 18.6M | ||
| Total Liabilities | Other Liabilities | 49.0K | 37.0K | 0.00 | 0.00 | |
| Total Liabilities | 25.1M | 27.4M | 32.1M | 18.6M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | -10.1M | -23.4M | -28.9M | 35.8M | ||
| Total Shareholder Equity | -10.1M | -23.4M | -28.9M | 35.8M | ||
| Share Information | Common Shares Outstanding | 25.9M | 25.9M | 28.7M | 46.4M | |
| Addtl. Info. | No data currently available for this section. | |||||
